Fundz

Octopath AI raises GBP 1.5M in a Seed funding round led by TwinPath Ventures. The capital will support clinical evaluation and regulatory work for its AI-powered diagnostic platform.

PRIVATENov 04, 2026

Amount Raised

£1.5 Million

Round Type

Seed

United KingdomBiotechnologyArtificial IntelligenceMachine LearningHealth Diagnostics

Investors

Innovate UKTwinPath Ventures

Description

Octopath AI, a UCL spinout specializing in AI tools for cancer pathology, raised GBP 1.5 million in seed funding. The funding is led by TwinPath Ventures with additional support from Innovate UK's Growth Catalyst grant. The capital will be used for clinical evaluation and regulatory approval of their AI diagnostic platform. Founded in 2026, Octopath AI aims to revolutionize cancer diagnostics with advanced technology.

Quick answer

Octopath AI raised £1.5 Million in a Seed round, dated November 3, 2026. Investors: Innovate UK and TwinPath Ventures. Octopath AI is based in United Kingdom.

How much did Octopath AI raise?
Octopath AI raised £1.5 Million in a Seed round on November 3, 2026.
Who invested in Octopath AI?
Innovate UK and TwinPath Ventures are named as investors in this round.
What does Octopath AI do?
Octopath AI is a spinout from the UCL Department of Medical Physics and Biomedical Engineering that specializes in artificial intelligence tools for cancer pathology.
Where is Octopath AI based and how big is it?
Octopath AI is based in United Kingdom. Fundz records about 5 employees.
Who are the decision-makers at Octopath AI?
Fundz holds 1 contact at Octopath AI, including the Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as Octopath AI that raised within 45 days of this round, from Fundz verified event records.

  • Alterra Labs raised $13M (Seed) on November 10, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Pathos AI raised $237M (Series E) on October 23, 2026.
  • AIBORN Ltd raised an undisclosed amount on October 5, 2026.
  • Codebreaker Labs raised $4.5M (Seed) on September 24, 2026.
  • Cascader raised an undisclosed amount (Seed) on September 23, 2026.

Who to call at Octopath AI, and when

A new round usually means Octopath AI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Octopath AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Octopath AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Octopath AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Octopath AI

Location

United Kingdom

About

Octopath AI is a spinout from the UCL Department of Medical Physics and Biomedical Engineering that specializes in artificial intelligence tools for cancer pathology. The company develops foundation models for tissue slide analysis, including tools like Kraken for cell classification and Nemo for immunohistochemistry analysis. Their goal is to provide single-cell resolution for cancer diagnostics. Founded in 2026, Octopath AI aims to support clinical evaluation and regulatory work for its AI-powered diagnostic platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Octopath AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsZhuoyan S., Co-FounderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Octopath AI's next move

See what Strategic adds

Octopath AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.